A likely reason why ALT was not selected as a key predictor is that in advanced liver disease, particularly with malnutrition or alcohol-related disease, pyridoxal-5′-phosphate can deficiency disproportionately reduces ALT activity relative to AST, leading to lower measured ALT levels (Domanski and Harrison, 2013). Here, GPT is linked to nutritional deficiency disease.